Moringa Acquisition Corp
Status: Deal Closed
U=S+W/2
W=S@11.5
IPO Proceeds, $M | $115.00M |
---|---|
IPO Date | Feb 17, 2021 |
CEO | Ilan Levin |
Left Lead | EarlyBirdCapital |
IPO Cash in Trust | 100.0% |
SPAC Tenor | 24 + 6 + 12 |
IPO Sector |
Technology
Technology in Israel |
IPO Geography | EEMEA |
Target Company | Silexion |
Deal Announced | Feb 22, 2024 |
Deal Size, $M | TBD |
Deal Sector | Healthcare |
Deal Geography | EEMEA |
SEC Filings | www.sec.gov |
Approval Vote | Aug 6, 2024 |
Amendment Vote | Aug 18, 2023 |
Closing Date | Aug 15, 2024 |
Formerly MACA
SLXN
SLXNW
Price | $2.87 |
---|---|
Last closing price | $2.86 |
Volume, today | 92,006 |
Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Moringa Acquisition Corp:
- Structure and cap table
- 7 directors & officers
- 35 filings and events
- 3 underwriters
- 1 deal advisors
- 3 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
Name | Age | Title |
---|---|---|
Ilan Levin | 54 | Chairman of the Board and Chief Executive Officer |
Gil Maman | 38 | Chief Financial Officer |
Dan Yalon | 48 | Advisor |
Craig Marshak | 61 | Vice Chairman |
Ruth Alon | 69 | Director |
Michael Basch | 36 | Director |
Eric Brachfeld | 59 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
EarlyBirdCapital | Joint BR | 4,750,000 | units |
Moelis | Joint BR | 4,750,000 | |
R.F. Lafferty | 500,000 | ||
10,000,000 | units | ||
Up-Front UW fee | 2.00 | % | |
BCMA | 3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.